Objectives and Key Deliverables
We are a global professional services firm notable for our work in turnaround management and performance improvement.
We are a urgently looking for an expert to assist us as a SME with one of our clients,
the world leader in development and distribution of allergy immunotherapy (AIT) products. Products are split into four categories: Sublingual (SLIT), Subcutaneous (SCIT), Veterinary products and Other products.
Our objective is to better understand the Company’s market dynamics in the US and in Europe / international markets and notably :
What is the continuum of care for AIT. From location of care (clinics vs. others), to diagnosis, to choice of extract, to delivery, to patient follow-up.
Within the realm of reimbursement, what drives the billing processes and the various reimbursement codes utilized?
There is a substantial difference in margins between SLIT and SCIT, where SCIT is most commonly utilized in the US. Some SLIT reimbursement is covered by private medical insurance in the US. Is this a growing market in the US?
What are the channels of delivery for allergen extracts and AIT?
What are the sales channels of delivery for AIT? How is the sales rep viewed and utilized in the choice of product and the delivery of AIT?
What is the focus of R&D in the industry today? Do you see clinical evidence as the critical path to gaining more broad based adoption?
Are named patient prescriptions (NPPs) a declining trend versus branded pharmaceuticals for AIT?